Antisense compounds, compositions and methods are provided for modulating
the expression of CD40. The compositions comprise antisense compounds,
particularly antisense oligonucleotides, targeted to nucleic acids
encoding CD40. Methods of using these compounds for modulation of CD40
expression and for treatment of diseases associated with CD40 are
provided.